🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the makers of Tylenol, asserting the corporations concealed alleged dangers that the medication posed to pediatric neurological development.

The court filing arrives a month after Former President Trump publicized an unproven link between using acetaminophen - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in young ones.

Paxton is suing Johnson & Johnson, which previously sold the medication, the sole analgesic approved for expectant mothers, and Kenvue, which now manufacturers it.

In a declaration, he stated they "misled consumers by gaining financially from suffering and promoting medication ignoring the potential hazards."

Kenvue says there is insufficient reliable data tying acetaminophen to autism.

"These companies deceived for years, knowingly endangering millions to boost earnings," Paxton, from the Republican party, stated.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its official site, the company also said it had "consistently assessed the pertinent research and there is no credible data that shows a proven link between using paracetamol and autism."

Associations speaking for doctors and health professionals concur.

The American College of Obstetricians and Gynecologists has stated paracetamol - the primary component in acetaminophen - is one of the few options for women during pregnancy to treat discomfort and elevated temperature, which can create significant medical dangers if ignored.

"In multiple decades of studies on the utilization of paracetamol in gestation, no reliable research has conclusively proven that the use of paracetamol in any stage of gestation causes neurodevelopmental disorders in offspring," the organization stated.

This legal action mentions recent announcements from the previous government in arguing the drug is allegedly unsafe.

Recently, Trump caused concern from health experts when he instructed expectant mothers to "fight like hell" not to consume acetaminophen when ill.

The US Food and Drug Administration then released a statement that doctors should think about restricting the use of Tylenol, while also declaring that "a proven link" between the medication and autism in young ones has not been proven.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had vowed in spring to undertake "extensive scientific investigation" that would establish the cause of autism spectrum disorder in a matter of months.

But experts cautioned that finding a sole reason of autism - considered by experts to be the consequence of a complicated interplay of genetic and environmental factors - would be difficult.

Autism is a type of lifelong neurodivergence and condition that influences how people perceive and engage with the environment, and is identified using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is seeking US Senate - claims the manufacturer and J&J "willfully ignored and tried to quiet the research" around acetaminophen and autism.

The lawsuit seeks to make the firms "destroy any marketing or advertising" that claims acetaminophen is reliable for expectant mothers.

This legal action parallels the complaints of a assembly of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in 2022.

A federal judge threw out the case, stating research from the plaintiffs' authorities was inconclusive.